Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHRH Treatment in the Elderly
NCT00807365Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Dec 2007
- Primary completion
- Apr 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of growth hormone releasing hormone 1-44 in growth hormone deficiency (GHD), sponsored by Johns Hopkins University. Primary endpoint: Change in Lean Body Mass at 2 years. Started Dec 2007; status: terminated.
02
Drugs
growth hormone releasing hormone 1-44
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00807365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807365.